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this 6-year period have occurred in our institution. Because the 
patients that we examined had their nuclear tests performed over a 
temporally limited period at the same institution, had a high rate of 
successful follow-up and were not affected by secular trends, the study 
population meets the conventional criteria typical of an inception 
cohort (4). 
Follow-up considerations. All patients included in the study had 
undergone thallium-201 myocardial perfusion SPECT at least 1 year 
before being contacted for follow-up. Follow-up was performed by 
scripted telephone interview by people with no knowledge of the 
patient's test results. In the case of patients or patient's next of kin who 
stated that either hard events (myocardial infarction or cardiac death) 
or interventions (cardiac catheterization, coronary artery bypass sur- 
gery, percutaneous transluminal coronary angioplasty) had occurred, 
these events were confirmed by hospital records or the physician's 
office records. All hard events were confirmed by check of hospital and 
private doctor's office records by people with no knowledge of the 
patient's test results. 
Myocardial infarctions were similarly confirmed by the presence of 
appropriate cardiac enzyme and electrocardiographic changes. Our 
lost to follow-up rate of <5% in this population is testimony to our 
success in contacting patients, We agree with Ferguson that the 
determination of the exact cause of death is imprecise, but all efforts 
were made to derive the most accurate final diagnosis possible. 
Despite the numerous criticisms of Ferguson, we believe that the 
conclusions reached by our study are valid and that the study provides 
new prognostic information in an important but infrequently studied 
patient group. Ferguson raises points regarding the performance of 
multivariate survival analysis that should be asked when any such study 
is read. Although there is a need to ensure that published statistical 
analyses are performed correctly, the methodologic descriptions of 
advanced statistical analyses (as that for SPECT imaging and process- 
ing) are usually excised from the final manuscript due to the page 
limitations placed on clinical journals, A complete methods ection 
from such a manuscript may well reach the length of Ferguson's letter. 
Finally, the level of methodologic detail provided in our report is 
typical of that of other investigators in and out of our field (5-14). 
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Cardiac Syndrome X 
I read with interest the long-term study of syndrome X by Kaski et al. 
(1) and noted that 29 of their 99 patients had hypercholesterolemia. 
Unfortunately, this comprehensive study failed to provide us with a 
detailed lipid profile of the patients; no attempt was made to treat 
them; and, moreover, the lipid issue was not addressed in their 
discussion pertaining to the possible mechanisms that may cause 
ischemia in this syndrome. Abnormal coronary vasodilation has been 
observed in hypercholesterolemic subjects without evidence of athero- 
sclerosis by either coronary angiography (2) or intravascular ultra- 
sound (3). Hypercholesterolemia ay be a dominant determinant for 
abnormal endothelium-mediated vasoactivity. Indeed cholesterol- 
lowering therapy may restore and improve ndothelial function (4). 
Thus, in this subgroup of symptomatic patients it is mandatory to 
monitor and lower their lipid levels, particularly the low density 
lipoprotein fraction, and to evaluate their clinical and exercise test 
responses to such therapy. 
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Reply 
I am grateful to Abinader for his comments. We are aware of the 
effects of hyperlipidemia on endothelial function. However, an assess- 
